Objective and mandate of the Commission. On the basis of the present agreement, the Commission is mandated to conclude, on behalf of the Participating Member States, Advance Purchase Agreements (“APA”) with vaccine manufacturers with the objective to procure vaccines for the purposes of combatting the COVID 19 pandemic at Union level. The Annex to this agreement sets out the negotiating directives for this purpose.
Appears in 4 contracts
Samples: Purchase Agreement (BioNTech SE), Advance Purchase Agreement (CureVac N.V.), Advance Purchase Agreement (CureVac N.V.)
